Document text
Principal Investigator: Charles M Rice
Organization: ROCKEFELLER UNIVERSITY
Fiscal Year: 2024
Award: $650,415
Funding agency: National Institute of Allergy and Infectious Diseases
Project Summary
The current pandemic has highlighted fundamental gaps in our knowledge about the replication strategies
of coronaviruses, and how these are affected by the host at both the organismal and cellular level. There is a
pressing need to understand how SARS-CoV-2 infection and host-cell responses trigger such a diverse set of
pathologies, and the roles played by viral variation, host genetics and underlying preconditions. As studies of
SARS-CoV-2 frequently utilize population-based assays that look hours to days post infection, information on
cellular and spatial variability are lost. Furthermore, host responses are communicative spatial processes subject
to signaling gradients that vary between cells. Thus, averages over populations obscure heterogeneity and
spatial separations, and miss the earliest viral and host behaviors due to lack of sensitivity.
To fill this gap, we developed experimental and computational approaches to quantify individual virion
entrance, establishment of the first replicative events, and production of viral RNAs and host responses in single
cells, all while maintaining sample spatial integrity. This project’s long-term objective is to apply this novel
approach to gain insights into SARS-CoV-2 biology distinct from those gleaned using traditional strategies. This
knowledge will provide new insight into the spectrum of COVID-19 disease outcomes and help guide future
therapeutic strategies.
To this end, single-molecule in situ analyses, including single molecule fluorescence in situ hybridization
(smFISH) and multiplexed error-robust FISH (MERFISH) will be applied to the study of SARS-CoV-2. Aim 1 will
quantify SARS-CoV-2 entry, replication and spread, and host transcriptional responses in cells of varying tissue
origin. These data will be used to develop a stochastic computational model to address the determinants of early
viral replication and the resulting cellular response. Aim 2 will examine the effect of host mutations or pre-existing
conditions that affect the type I interferon (IFN) response and have been associated with severe COVID-19, as
well as emerging viral Variants of Concern. Aim 3 will model patient comorbidities in vivo using mouse models
of SARS-CoV-2 infection, identifying the functional and spatial consequences of host responses, including IFN
and other cytokine expression, in the respiratory tract and lung. We will further utilize these in vivo models to
understand why pathogenesis and disease outcome differ depending on the inoculum dose and the age of the
animal. Together, our multidisciplinary approach utilizing techniques and information from systems-level virology,
spatial transcriptomics, host genetics, computational biology, and innate immunity provides a powerful means of
probing questions central to understanding clinical outcome and informing life-saving interventions.
Terms: <(IFN) α><(IFN)-α><(IFN)α><2019 novel corona virus><2019 novel coronavirus><2019-nCoV><Address><Affect><Age><Alferon><Animals><Assay><Autoantibodies><Behavior><Bioassay><Biological Assay><Biology><Body Tissues><COVID crisis><COVID epidemic><COVID pandemic><COVID-19><COVID-19 crisis><COVID-19 epidemic><COVID-19 era><COVID-19 global health crisis><COVID-19 global pandemic><COVID-19 health crisis><COVID-19 infection><COVID-19 pandemic><COVID-19 period><COVID-19 public health crisis><COVID-19 virus><COVID-19 virus infection><COVID-19 years><COVID19 infection><COVID19 virus><CRISPR><CRISPR/Cas system><CV-19><Cell Body><Cell Communication and Signaling><Cell Signaling><Cells><Cellular biology><Cessation of life><Clinical><Clustered Regularly Interspaced Short Palindromic Repeats><CoV-2><CoV2><Complex><Computational Biology><Computer Models><Computerized Models><Coronaviridae><Coronavirus><Coronavirus Infectious Disease 2019><Cricetinae><Data><Data Set><Data Systems><Death><Disease><Disease Outcome><Disorder><Dose><Encapsulated><Environment><Epidemiologic Monitoring><Epidemiologic surveillance><Epidemiological Monitoring><Epidemiological surveillance><Epidemiology Surveillance><Escape Mutant><Event><Expression Signature><FISH Technic><FISH Technique><FISH analysis><FISH assay><Fluorescence In Situ Hybridization><Fluorescent in Situ Hybridization><Future><Gene Expression Profile><Gene Transcription><Gene variant><Genetic><Genetic Alteration><Genetic Change><Genetic Diversity><Genetic Transcription><Genetic Variation><Genetic defect><Genomics><Genotype><Glean><Hamsters><Hamsters Mammals><Heterogeneity><Hour><Human Genetics><IFN><IFN Alpha><IFN α><IFN-α><IFNa><IFNα><IT Systems><Image><Immune response><Immunity><Immunological response><In Situ><In Vitro><Individual><Infection><Information Systems><Information Technology Systems><Innate Immunity><Interferon Alfa-n3><Interferon Type I><Interferon alpha><Interferon-α><Interferons><Intervention><Intervention Strategies><Intracellular Communication and Signaling><Investigation><Kinetics><Knock-in><Knock-out><Knockout><Knowledge><Leukocyte Interferon><Life><Link><Lung><Lung Respiratory System><Lymphoblast Interferon><Lymphoblastoid Interferon><Measures><Methods><Mice><Mice Mammals><Modeling><Molecular><Monkeys><Murine><Mus><Mutation><Native Immunity><Natural Immunity><Nature><Non-Specific Immunity><Nonspecific Immunity><Outcome><Pathogenesis><Pathology><Pathway interactions><Patient outcome><Patient-Centered Outcomes><Patient-Focused Outcomes><Patients><Persons><Phenotype><Play><Predisposition><Process><Production><Pulmonary Body System><Pulmonary Organ System><RNA Expression><Respiratory System><Respiratory Tracts><Respiratory tract structure><Risk Reduction><Role><SARS corona virus 2><SARS-CO-V2><SARS-COVID-2><SARS-CoV-2><SARS-CoV-2 epidemic><SARS-CoV-2 global health crisis><SARS-CoV-2 global pandemic><SARS-CoV-2 infection><SARS-CoV-2 pandemic><SARS-CoV2><SARS-CoV2 infection><SARS-associated corona virus 2><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-coronavirus-2 epidemic><SARS-coronavirus-2 pandemic><SARS-related corona virus 2><SARS-related coronavirus 2><SARSCoV2><Sampling><Severe Acute Respiratory Coronavirus 2><Severe Acute Respiratory Distress Syndrome CoV 2><Severe Acute Respiratory Distress Syndrome Corona Virus 2><Severe Acute Respiratory Distress Syndrome Coronavirus 2><Severe Acute Respiratory Syndrome CoV 2><Severe Acute Respiratory Syndrome CoV 2 epidemic><Severe Acute Respiratory Syndrome CoV 2 pandemic><Severe Acute Respiratory Syndrome-associated coronavirus 2><Severe Acute Respiratory Syndrome-related coronavirus 2><Severe acute respiratory syndrome associated corona virus 2><Severe acute respiratory syndrome coronavirus 2><Severe acute respiratory syndrome coronavirus 2 epidemic><Severe acute respiratory syndrome coronavirus 2 infection><Severe acute respiratory syndrome coronavirus 2 pandemic><Severe acute respiratory syndrome related corona virus 2><Severity of illness><Signal Transduction><Signal Transduction Systems><Signaling><Susceptibility><Symptoms><System><Techniques><Testing><Therapeutic><Time><Tissues><Transcription><Vaccines><Variant><Variation><Viral><Viral Diseases><Viral Genetics><Virion><Virus><Virus Diseases><Virus Particle><Virus Replication><Wuhan coronavirus><age associated difference><age associated effects><age based difference><age dependent difference><age dependent variation><age difference><age effect><age related difference><age related effects><age related variation><age specific difference><ages><aging effect><allele variant><allelic variant><autoimmune antibody><autoreactive antibody><biological signal transduction><cell biology><cell type><clinical relevance><clinically relevant><co-morbid><co-morbidity><comorbidity><computational modeling><computational models><computer based models><computer biology><computerized modeling><corona virus><coronavirus disease 2019><coronavirus disease 2019 crisis><coronavirus disease 2019 epidemic><coronavirus disease 2019 global health crisis><coronavirus disease 2019 global pandemic><coronavirus disease 2019 health crisis><coronavirus disease 2019 infection><coronavirus disease 2019 pandemic><coronavirus disease 2019 public health crisis><coronavirus disease 2019 virus><coronavirus disease crisis><coronavirus disease epidemic><coronavirus disease pandemic><coronavirus disease-19><coronavirus disease-19 global pandemic><coronavirus disease-19 pandemic><coronavirus disease-19 virus><coronavirus infectious disease-19><current pandemic><cytokine><differ by age><difference across age><difference in age><disease severity><fitness><gene expression pattern><gene expression signature><genetic variant><genome mutation><genomic variant><hCoV19><host response><human disease><imaging><immune system response><immunoresponse><impact of age><in vivo><in vivo Model><infected with COVID-19><infected with COVID19><infected with SARS-CoV-2><infected with SARS-CoV2><infected with coronavirus disease 2019><infected with severe acute respiratory syndrome coronavirus 2><influence of age><insight><interdisciplinary approach><interventional strategy><knockin><life-threatening COVID><life-threatening COVID-19><life-threatening SARS-CoV-2><life-threatening coronavirus disease><life-threatening coronavirus disease 2019><life-threatening severe acute respiratory syndrome coronavirus 2><mouse genetics><mouse model><multidisciplinary approach><murine model><mutant><nCoV2><neutralizing antibody><new approaches><novel approaches><novel strategies><novel strategy><overpopulation><pandemic><pandemic disease><pathway><patient oriented outcomes><population based><present pandemic><pulmonary><reduce risk><reduce risks><reduce that risk><reduce the risk><reduce these risks><reduces risk><reduces the risk><reducing risk><reducing the risk><response><risk-reducing><self reactive antibody><serious COVID><serious COVID-19><serious SARS-CoV-2><serious coronavirus disease><serious coronavirus disease 2019><serious severe acute respiratory syndrome coronavirus 2><severe COVID><severe COVID-19><severe COVID19><severe SARS-CoV-2><severe acute respiratory syndrome coronavirus 2 global health crisis><severe acute respiratory syndrome coronavirus 2 global pandemic><severe coronavirus disease><severe coronavirus disease 19><severe coronavirus disease 2019><severe severe acute respiratory syndrome coronavirus 2><single molecule><social role><spatiotemporal><transcriptional profile><transcriptional signature><transcriptomics><variants of concern><variation by age><viral RNA><viral infection><viral multiplication><viral replication><virology><virus RNA><virus genetics><virus infection><virus multiplication><virus-induced disease>